The expression of S100A8 at the protein level was correlated with tumor stage (p < 0.001), ER status (p < 0.001), PR status (p < 0.001), HER2 status (p = 0.012), and relapse (p = 0.002) in breast cancer patients. Here, ERBB2 is linked to breast carcinoma.